|
1. Herpin D, Conte D. Assessment of the
antihypertensive effect of lisinopril using 24-hour ambulatory monitoring.
J Hum Hypertens. 1989;3:11-15.
2. The Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure. Bethesda, Md: National Heart, Lung, and
Blood Institute. NIH Publication 03-5233. May 2003.
3. Agardh C-D, Garcia-Puig J, Charbonnel
B, Angelkort B, Barnett AH. Greater reduction of urinary albumin
excretion in hypertensive type II diabetic patients with incipient
nephropathy by lisinopril than by nifedipine. J Hum Hypertens.
1996;10:185-192.
4. Mogensen CE, Neldam S, Tikkanen I, et
al for the CALM study group. Randomised controlled trial of dual
blockade of renin-angiotensin system in patients with hypertension,
microalbuminuria, and non-insulin dependent diabetes: the candesartan
and lisinopril microalbuminuria (CALM) study. BMJ. 2000;321:1440-1444.
5. Crepaldi G, Carraro A, Brocco E, et
al. Hypertension and non-insulin-dependent diabetes: a comparison
between an angiotensin-converting enzyme inhibitor and a calcium
antagonist. Acta Diabetol. 1995;32:203-208.
6. Rossing P, Tarnow L, Boelskifte S, et
al. Differences between nisoldipine and lisinopril on glomerular
filtration rates and albuminuria in hypertensive IDDM patients with
diabetic nephropathy during the first year of treatment. Diabetes.
1997;46:481-487.
7. Giles TD, Katz R, Sullivan JM, et al
for the Multicenter Lisinopril-Captopril Congestive Heart Failure
Study Group. Short- and long-acting angiotensin-converting enzyme
inhibitors: a randomized trial of lisinopril versus captopril in
the treatment of congestive heart failure. J Am Coll Cardiol.
1989;13:1240-1247.
8. Morisco C, Condorelli M, Crepaldi
G, et al. Lisinopril in the treatment of congestive heart failure
in elderly patients: comparison versus captopril. Cardiovasc
Drugs Ther. 1997;11:63-69.
9. Lewis GRJ. Lisinopril versus placebo
in older congestive heart failure patients. Am J Med. 1988;85(suppl
3B):48-54.
10. Gruppo Italiano per lo Studio della
Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril
and transdermal glyceryl trinitrate singly and together on 6-week
mortality and ventricular function after acute myocardial infarction.
Lancet. 1994;343:1115-1122.
|
